Showing results (51-60 of 175) with videos related to
Sort By:
Pageof 18
Investigational New Drugs|April 1, 1992
Echinomycin (NSC 526417) in recurrent and metastatic squamous cell carcinoma of the cervix. A phase II trial of the Gynecologic Oncology Group (GOG)H B Muss, J A Blessing, G L Eddy, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1989
A phase II evaluation of mitolactol in patients with advanced squamous cell carcinoma of the cervix: a Gynecologic Oncology Group StudyF B Stehman, J A Blessing, R McGehee, et al.American Journal of Obstetrics and Gynecology|June 15, 1985
Human lymphoblastoid interferon in the treatment of advanced epithelial ovarian malignancies: a Gynecologic Oncology Group StudyG Abdulhay, P J DiSaia, J A Blessing, et al.Cancer Treatment Reports|January 1, 1979
Phase II trial of adriamycin in the treatment of advanced or recurrent endometrial carcinoma: a Gynecologic Oncology Group studyJ T Thigpen, H J Buchsbaum, C Mangan, et al.American Journal of Clinical Oncology|February 1, 1986
Phase II trial of piperazinedione in the treatment of advanced or recurrent endometrial carcinoma. A Gynecologic Oncology Group StudyJ T Thigpen, J A Blessing, H D Homesley, et al.American Journal of Clinical Oncology|April 1, 1987
Hematologic monitoring in patients with cancer. A study of the Gynecologic Oncology GroupS L Curry, H B Muss, J A Blessing, et al.Investigational New Drugs|May 1, 1990
Phase II study of N-methylformamide (N-MF) (NSC 3051) in patients with advanced epithelial ovarian cancer. A Gynecologic Oncology Group studyW P McGuire, J A Blessing, J S Berek, et al.American Journal of Clinical Oncology|December 1, 1993
A phase II trial of tricyclic nucleoside phosphate in patients with advanced squamous cell carcinoma of the cervix. A Gynecologic Oncology Group StudyL G Feun, J A Blessing, R J Barrett, et al.American Journal of Clinical Oncology|August 1, 1983
Phase II study of maytansine in the treatment of advanced or recurrent squamous cell carcinoma of the cervix. A Gynecologic Oncology Group studyJ T Thigpen, C E Ehrlich, J Conroy, et al.Gynecologic Oncology|May 17, 2001
A Phase II study of topotecan in patients with squamous cell carcinoma of the cervix: a gynecologic oncology group studyL I Muderspach, J A Blessing, C Levenback, et al.Pageof 18